Sareum Holdings PLC exercises issued warrants
Sareum Holdings plc said it has exercised warrants. The company is a clinical-stage biotechnology firm developing next-generation kinase inhibitors for autoimmune disease.
RNS Number: 1768T Sareum Holdings PLC 02 September 2026 Sareum Holdings plc("Sareum" or the "Company")Exercise of WarrantsCambridge, UK, 2 September 2026 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease…